Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Pall Life Sciences Launches Kleenpak® Presto Sterile Connectors for Genderless Fluid Transfer Applications

Pall Life Sciences
Posted on: 14 Oct 16

Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, is pleased to announce the launch of the Kleenpak® Presto sterile connector to be used in a wide range of applications in upstream, downstream, and formulation and filling.

“We launched the Presto genderless sterile connector family in direct response to customer demand for a reliable, robust universal single-use fluid handling solution,” said the company’s President of Single Use Technologies, Mario Philips. “With its intuitive operation and easy to use features – we worked closely on this new generation design with our customers to ensure even greater levels of sterility assurance.”

The Kleenpak Presto sterile connector is a genderless technology for the sterile connection of two fluid paths even in uncontrolled environments. The connectors are available in ¼ in., ⅜ in., ½ in. and ⅝ in. hose barb sizes, and with ½ in. sanitary connections, and are made from Bisphenol-A free polyethersulfone. The connectors can be used for a wide range of applications and are 100% inspected at point of manufacturer with device traceability and serialization linked to this 100% quality control process.

To learn more about Kleenpak Presto single-use genderless connectors, please visit:

And see them in action here:

Pall Corporation provides critical fluid management solutions to global life sciences and industrial manufacturing customers. The biopharmaceutical division of Pall Life Sciences features an unmatched portfolio of traditional and single-use products with custom service support from R&D to clinical phases to production. Pall is committed to continuously improving bioprocesses to enable users to advance global health with safe, environmentally responsible technologies. Stay up to date with our latest progress at: www.pall.comLinkedInTwitter; and YouTube.

View source version on

Business Wire

Last updated on: 14/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.